Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-01-12

Clinical Trial Update: Pemoline in the Treatment of Stimulant Dependence - 5 [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating pemoline for cocaine-related disorders was withdrawn (sponsor: National Institute on Drug Abuse).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pemoline (pemoline)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Cocaine-Related Disorders | Phase 2 | Status: WITHDRAWN